Robert Estey is a highly experienced pharmaceutical executive and CEO at Per Os Biosciences. He has studied an MBA at Rochester Institute of Technology and a BA at Colgate University. With more than three decades of experience, he has worked in several executive positions. Robert has co-founded ANI Pharmaceuticals and served as its Chief Business Officer. He was also the CFO at Xanodyne Pharmaceuticals, Vice President of Finance at Alpharma USPD, and Vice President of Finance at Florida Tile Industries. He started his career in earlier companies where he has held financial and operational positions.

Robert's expertise revolves around unique, tableted delivery systems that absorb quickly through the oral mucosa with high bioavailability of actives. He has patented a unique chewing gum manufacturing process (3 patents and counting) that allows the development of one-of-a-kind dietary supplement or food products, with pharmaceutical products as future targets. Robert and his team specialize in incorporating CBD into their tableted product formats of chewing gum, lozenges/mints, and chewable tablets.